11 phd-in-mathematical-modelling-population Postdoctoral positions at University of Copenhagen in Denmark
-
University of Copenhagen, Dept of Mathematical Sciences Position ID: 821-PD2025 [#26843] Position Title: Position Type: Postdoctoral Position Location: Copenhagen, Copenhagen 2100, Denmark [map
-
University of Copenhagen, Dept of Mathematical Sciences Position ID: 821-SPTIE2025 [#26845] Position Title: Position Type: Postdoctoral Position Location: Copenhagen, Copenhagen 2100, Denmark [map
-
transcriptomics and spatial lipidomics to create quantitative models of immune-metabolic communication across tissues The project combines controlled mouse models of maternal inflammation with advanced multi-omics
-
, doi:10.1126/sciadv.adn3448 ) Maternal immune activation and fetal metabolic adaptation (Nat Commun 2024, doi:10.1038/s41467-024-48492-x ) Microfluidic models of pH and oxygen gradients in tumors
-
(Science Advances 2024, doi:10.1126/sciadv.adn3448 ) Microfluidic models of pH and oxygen gradients in tumors (bioRxiv 2025, doi:10.1101/2025.07.05.663284 ) Tumor microenvironment acidosis favors
-
? What are triggers for allergic inflammation? How do environmental and genetic factors combine to mediate allergy? To explore these questions, we utilise mouse models of allergy and infection and combine
-
, palaeoanthropology, and archaeology. In particular, we have strong interests in 1) understanding the phylogenetic and population genetic relationships between past hominins within this period, 2) exploring
-
Infrastructure? No Offer Description We are looking for a highly motivated and dynamic Postdoctoral fellow with a PhD or equivalent degree to join the Merino Group at the Novo Nordisk Foundation Center for Basic
-
strong background in experimental economics (preferably from African settings) while the other should have experience in SAM/CGE modelling, preferably related to green reform issues and challenges
-
and supervisors. The PhD project is part of the research project NeuroGen Computing Research Project, which is financed by Novo Nordisk Foundation. Start date is (expected to be) February 1st 2026 or as